Results 81 to 90 of about 4,131 (170)

COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma

Frontiers in Pharmacology
BackgroundVasculogenic Mimicry (VM) can reduce the efficacy of anti-angiogenesis and promote distant metastasis in hepatocellular carcinoma (HCC). Our previous studies have found that Celastrus orbiculatus extract (COE) can inhibit the VM formation in ...
Jue Chen, Jue Chen, Jue Chen, Jue Chen, Shu-Ying Dai, Su Wu, Meng-Ke Wu, Ke-Ke Yu, Jun-Chi Liu, Jia-Yu Chang, Yan-Qing Liu, Yan-Qing Liu, Yan-Qing Liu, Yan-Qing Liu   +13 more
doaj   +1 more source

ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment

Molecular Cancer
Background The hypoxic tumor microenvironment is a key factor that promotes metabolic reprogramming and vascular mimicry (VM) in ovarian cancer (OC) patients.
Juan Zhang, Fan Ouyang, Anbo Gao, Tian Zeng, Ming Li, Hui Li, Wenchao Zhou, Qing Gao, Xing Tang, Qunfeng Zhang, Xiaomin Ran, Gang Tian, Xiyun Quan, Zhenzi Tang, Juan Zou, Yifei Zeng, Yunzhu Long, Yukun Li   +17 more
doaj   +1 more source

Targeting Vasculogenic Mimicry in Cancer

Like any tissue, tumours depend on a constant blood supply to deliver oxygen and nutrients. Tumour neovascularization is achieved most frequently through the process of angiogenesis, in which tumour cells secrete extracellular factors to recruit host endothelium to grow into the neoplastic tissue.
openaire   +1 more source

Vasculogenic mimicry and breast cancer prognosis: Insights into predictive model development. [PDF]

Oncol Lett
Wu Z, Teng Y, Huang S, Shi S, Qiu P, Shan L, Lin M, Zhang Y.   +7 more
europepmc   +1 more source

Research progress on vasculogenic mimicry in colorectal cancer: mechanisms and therapeutic. [PDF]

Cell Div
Zewei J, Haiyan Z.
europepmc   +1 more source

COL10A1 overexpression potentially contributes to poor outcomes in breast cancer via autophagy and vasculogenic mimicry. [PDF]

Transl Cancer Res
Gao L, Yang J, Fan X, Ling Y, Jiang X, Jin X, Xu H, Ling Y, Yu L.   +8 more
europepmc   +1 more source

A novel prognostic model based on vasculogenic mimicry in ovarian cancer. [PDF]

Transl Cancer Res
Song Y, Cai S, Ma J, Yang Y, Chen Y, Li R, Meng F.   +6 more
europepmc   +1 more source

A vasculogenic mimicry subtype unveiled by integrated multi-omics predicts prognosis and guides immunotherapy in MIBC. [PDF]

Front Bioinform
Wei L, Liao S, Feng X, Tang Z, Tang Z, Tao Y, Zheng Y, Liu T, Qin Z, Cao X, Tang Z, Liu Y, Cai Y, Li T, Feng C, Wang Q, Tang Z.   +16 more
europepmc   +1 more source

Distinct Transcriptional and Migratory Programs Are Associated with Vasculogenic Mimicry Heterogeneity in Triple-Negative Breast Cancer. [PDF]

Cancers (Basel)
Madhavan-Kadali S, Cho HM, Sneh T, Bloch N, Rosenblatt JD, Samson AO, Gil-Henn H.   +6 more
europepmc   +1 more source

Tumor Cell Vasculogenic Mimicry

The American Journal of Pathology, 2012
Seftor, Richard E.B., Hess, Angela R., Seftor, Elisabeth A., Kirschmann, Dawn A., Hardy, Katharine M., Margaryan, Naira V., Hendrix, Mary J.C.   +6 more
openaire   +1 more source